AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER’S, PARKINSON’S, AND ALS RESEARCH. GCM [Internet]. 2026 Jun. 9 [cited 2026 Oct. 30];1(6):709-21. Available from: https://www.econferencia.com/index.php/5/article/view/1216